Evidence map›Paper›PMID 42650939›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Florastamin Uptake on PSMA PET/CT as an Imaging Biomarker of Tumor Aggressiveness in Prostate Cancer.

Yeongjoo Lee, Joo Hyun O, Seunggyun Ha, Chansoo Park, Dongho Shin, Hyong Woo Moon, Ji Youl Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yeongjoo LeeDivision of Nuclear Medicine, Department of Radiology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0003-2978-4913
Joo Hyun ODivision of Nuclear Medicine, Department of Radiology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0002-6568-5915
Seunggyun HaDivision of Nuclear Medicine, Department of Radiology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Chansoo ParkResearch Institute of Labeling, FutureChem Co., Ltd., Seoul 04794, Republic of Korea.ORCID 0000-0001-9150-0593
Dongho ShinDepartment of Urology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0001-8496-8825
Hyong Woo MoonDepartment of Urology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0002-9352-3411
Ji Youl LeeDepartment of Urology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0001-6775-1157

Funding

FutureChem (South Korea) NCT05004285National Research Foundation of Korea RS-2022-NR069528
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

East AsianflorastaminPET/CTprostate cancer

Identifiers

PMID42650939
PMCPMC13511251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.